Home Cart Sign in  
Chemical Structure| 579-13-5 Chemical Structure| 579-13-5

Structure of Oligomycin A
CAS No.: 579-13-5

Chemical Structure| 579-13-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oligomycin A, a mitochondrial ATP synthase inhibitor, is isolated from Streptomyces species, exhibits anti-tumor and antibiotic activity.

Synonyms: MCH 32

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Wei, Yao ; Miao, QianQian ; Zhang, Qian ; Mao, Shiyu ; Li, Mengke ; Xu, Xing , et al.

Abstract: It is generally thought that under basal conditions, neurons produce ATP; mainly through mitochondrial oxidative phosphorylation (OXPHOS),; and glycolytic activity only predominates when neurons are activated; and need to meet higher energy demands. However, it remains unknown; whether there are differences in glucose metabolism between neuronal; somata and axon terminals. Here, we demonstrated that neuronal somata; perform higher levels of aerobic glycolysis and lower levels of OXPHOS; than terminals, both during basal and activated states. We found that the; glycolytic enzyme pyruvate kinase 2 (PKM2) is localized predominantly in; the somata rather than in the terminals. Deletion of Pkm2 in mice results in; a switch from aerobic glycolysis to OXPHOS in neuronal somata, leading; to oxidative damage and progressive loss of dopaminergic neurons. Our; findings update the conventional view that neurons uniformly use OXPHOS; under basal conditions and highlight the important role of somatic aerobic; glycolysis in maintaining antioxidant capacity.

Purchased from AmBeed: ; ;

Alternative Products

Product Details of Oligomycin A

CAS No. :579-13-5
Formula : C45H74O11
M.W : 791.06
SMILES Code : O=C(/C=C/[C@H](C)[C@@H](O)[C@H](C)C([C@H](C)[C@@H](O)[C@@H]1C)=O)O[C@@]([C@@H]2C)([H])[C@H](C)[C@@]3(CC[C@H](C)[C@H](C[C@H](O)C)O3)O[C@@]2([H])CC[C@@H](CC)/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C1=O
Synonyms :
MCH 32
MDL No. :MFCD00065705
InChI Key :MNULEGDCPYONBU-AWJDAWNUSA-N
Pubchem ID :52947716

Safety of Oligomycin A

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • ATPase

In Vitro:

Cell Line
Concentration Treated Time Description References
C3H10T1/2 cells 0.2 μM Measure oxygen consumption rate to assess mitochondrial function Nutrients. 2017 Jun 30;9(7):680.
γδT17 cells 10 μM 3 days Inhibited the differentiation of γδT17 cells and eliminated the difference between Il27ra deficient and sufficient γδT17 cells Cell Death Dis. 2024 Jul 9;15(7):491.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.26mL

0.25mL

0.13mL

6.32mL

1.26mL

0.63mL

12.64mL

2.53mL

1.26mL

References

 

Historical Records

Categories